Eleni Gavriilaki, MD, PhD, received her medical degree from the Aristotle University of Thessaloniki in Thessaloniki, Greece, in 2010, where she then participated in a postgraduate program in medical research methodology. In 2014, Dr Gavriilaki completed a residency in internal medicine at the General Hospital of Edessa in Thessaloniki, Greece, followed by a postdoctoral fellowship at the John Hopkins School of Medicine in Baltimore, MD. In 2016, Dr Gavriilaki completed her PhD with the Aristotle University of Thessaloniki and went on to become a Hematology Fellow at the George Papanikolaou Hospital in Thessaloniki, Greece.
Dr Gavriilaki has served as a Hematologist at the George Papanikolaou Hospital since 2020.
Speaking on monoclonal antibody therapies for TA-TMA
Dr Gavriilaki’s research is primarily in the field of transplantation. She has published many studies investigating the treatment of transplant-associated thrombotic microangiopathy (TA-TMA), an endothelial damage syndrome that’s increasingly found as a complication of autologous and allogeneic hematopoietic cell transplantation. Many of these investigations have explored the therapeutic potential of monoclonal antibodies.